dr. maziarz on unanswered questions with car t-cell therapy in dlbcl
Published 5 years ago • 166 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
1:58
dr. maziarz on sustained responses with tisagenlecleucel in dlbcl
-
1:42
unanswered questions in car-t therapies
-
4:27
car-t gives sustained disease control in r/r adult dlbcl: updated juliet analysis
-
2:22
dr. leslie on the development of car t-cell therapy in dlbcl and mcl
-
0:48
dr. tzachanis on the likelihood of cure with car t-cell therapy in lymphoma
-
2:17
dr. shadman on next steps for car t-cell therapy in dlbcl
-
2:24
questions to ask your doctor about car t-cell therapy
-
2:48
the novel icaht grading system to predict toxicity following car t-cell therapy
-
1:06
dr. mesa on the potential utility of car t-cell therapy in mpns
-
9:05
understanding car t-cell therapy for lymphoma with andrew zelenetz, md, phd
-
1:37
loncastuximab tesirine as a consolidation strategy post-car t-cell therapy in dlbcl
-
0:43
dr. martin on potential for car t-cell therapy in mcl landscape
-
6:13
lymphoma: overview of chimeric antigen receptor (car) t cells
-
15:44
panel discussion on immune therapies for lymphoma - car t-cell therapy and the question of cure
-
11:50
fda approval in myeloma, priority review in dlbcl, application accepted of a biosimilar, and more
-
5:47
allogenic car t-cell therapy in lymphoma
-
2:02
car t-cell therapy
-
0:57
car t-cell therapy: how does it work?
-
12:04
day 1 round up: car t-cell products